ENU Medicines Revenue

Biotechnology Research • Palo Alto, California, United States • 1-10 Employees

ENU Medicines revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at ENU Medicines

Oscar Huang

Co-founder, VP of Lead Discovery & Head of Protein Degradation

Company overview

Headquarters	Palo Alto, California, United States
Website	enumed.com
NAICS	541714
Founded	2025
Employees	1-10

About ENU Medicines

ENU Medicines is developing first-in-class therapeutics for food allergy and IgE-mediated diseases, grounded in discoveries from large-scale, high-throughput forward genetics screening in physiologically relevant animal models. Our pipeline targets novel, genetically validated regulators of allergic immune responses, including proteins that control IgE antibody production at its source. By leveraging tissue-restricted protein degradation and other precision modalities, we aim to deliver highly selective, disease-modifying therapies with improved safety and efficacy.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

ENU Medicines has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

ENU Medicines has never raised funding before.

Frequently asked questions

ENU Medicines is located in Palo Alto, California, US.

ENU Medicines generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

ENU Medicines has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ENU Medicines was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

ENU Medicines has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at ENU Medicines

Oscar Huang

Co-founder, VP of Lead Discovery & Head of Protein Degradation

4.8

40,000 users